# Perioperative Dexmedetomidine and Long-term Survival After Cancer Surgery

> **NCT06030804** · NA · RECRUITING · sponsor: **Peking University First Hospital** · enrollment: 4532 (estimated)

## Conditions studied

- Elderly
- Cancer Surgery
- Dexmedetomidine
- Long-Term Survivors

## Interventions

- **DRUG:** Dexmedetomidine
- **DRUG:** Placebo

## Key facts

- **NCT ID:** NCT06030804
- **Lead sponsor:** Peking University First Hospital
- **Sponsor class:** OTHER
- **Phase:** NA
- **Study type:** INTERVENTIONAL
- **Status:** RECRUITING
- **Start date:** 2023-09-12
- **Primary completion:** 2025-09
- **Final completion:** 2028-10
- **Target enrollment:** 4532 (ESTIMATED)
- **Last updated:** 2025-07-31

## Collaborators

- [object Object]

## Primary source

ClinicalTrials.gov registry: https://clinicaltrials.gov/study/NCT06030804

## Citation

> US National Library of Medicine, ClinicalTrials.gov registration NCT06030804, "Perioperative Dexmedetomidine and Long-term Survival After Cancer Surgery". Retrieved via AI Analytics 2026-06-02 from https://api.ai-analytics.org/clinical/NCT06030804. Licensed CC0.

---

*[Clinical trials dataset](/datasets/clinical-trials) · CC0 1.0*